Results 1 to 10 of about 1,482,126 (355)

Antinuclear antibodies in COVID 19 [PDF]

open access: yesClinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al. on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19). Both we and Chang and collaborators described the presence and significance of ANAs in patients with COVID‐19.
Paolo Muratori   +3 more
doaj   +6 more sources

The Past, Present, and Future in Antinuclear Antibodies (ANA) [PDF]

open access: yesDiagnostics, 2022
Autoantibodies are a hallmark of autoimmunity and, specifically, antinuclear antibodies (ANAs) are the most relevant autoantibodies present in systemic autoimmune rheumatic diseases (SARDs).
Juan Irure-Ventura, Marcos López-Hoyos
doaj   +3 more sources

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +7 more sources

Increasing Prevalence of Antinuclear Antibodies in the United States [PDF]

open access: yesArthritis Rheumatol, 2022
Growing evidence suggests increasing frequencies of autoimmunity and autoimmune diseases, but findings are limited by the lack of systematic data and evolving approaches and definitions.
G. Dinse   +7 more
semanticscholar   +2 more sources

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis? [PDF]

open access: yesFront Immunol, 2022
Systemic sclerosis (SSc) is a connective tissue disease characterized by extensive fibrosis of the skin and internal organs, associated with vasculopathy and autoimmune features.
Aurélien Chepy   +5 more
semanticscholar   +2 more sources

Understanding antinuclear antibodies [PDF]

open access: hybridThe Journal of the American Osteopathic Association, 1991
The American College of Rheumatology (formerly the American Rheumatism Association) diagnostic criteria for connective tissue disorders frequently include positive antinuclear antibody (ANA) assays. Proper interpretation of these tests requires an understanding of the principles governing ANA assays.
Bernard R. Rubin, Pertusi Rm
openaire   +4 more sources

Can Antinuclear Antibodies (ANA) be Monoclonal? [PDF]

open access: yesCase Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman   +7 more
doaj   +2 more sources

ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA [PDF]

open access: bronzeThe Journal of Experimental Medicine, 1966
Antinuclear antibodies were detected by immunofluorescence in most sera from rabbits immunized with whole human serum emulsified in Freund's complete adjuvant. Four of 14 sera from rabbits immunized with Cohn fractions III, IV-1, or IV-4 also gave positive nuclear fluorescence with human leukocyte nuclei.
John H. Vaughan, Eugene V. Barnett
openaire   +4 more sources

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

open access: yesIndian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti   +5 more
doaj   +2 more sources

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students [PDF]

open access: yesJournal of Primary Care & Community Health
Introduction: Antinuclear antibodies (ANA) are the hallmark of many connective tissue disorders (including lupus), which comprise roughly 5% to 10% of chronic debilitating diseases causing morbidity and mortality.
Karol Laskowski   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy